New drug LEO 153339 tested in healthy people for safety
NCT ID NCT04883333
First seen May 01, 2026 · Last updated May 01, 2026
Summary
This early-stage study tested the safety of a new drug called LEO 153339 in 108 healthy adults aged 18 to 65. Participants received either a single dose or multiple doses of the drug or a placebo. The goal was to see how the body handles the drug and whether it causes any side effects. This study did not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
LEO Pharma Investigational Site
Groningen, NZ, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.